FirstWord Pharma

The latest global #pharma news, insights, analysis, and views providing you with an information edge. FirstWord Pharma. Where people who know first, go first.

[FirstWord Pharma @fwpharma]

Elevar, Hengrui's liver cancer duo gets handed third FDA rejection https://t.co/YrQCzc3TuT

[FirstWord Pharma @fwpharma]

FDA broadens use of perioperative Padcev-Keytuda combo $ALPMY $PFE https://t.co/kC11Tvj3lG

[FirstWord Pharma @fwpharma]

Pfizer names Danna Breen head of obesity discovery $PFE https://t.co/7rh4r6itpp

[FirstWord Pharma @fwpharma]

GSK's Hansoh-partnered B7-H3 ADC shows survival benefit in lung cancer study $GSK https://t.co/Va2xdMUGUz

[FirstWord Pharma @fwpharma]

German lawmakers pass healthcare cost-saving measures https://t.co/Y2JC6vSYCY

[FirstWord Pharma @fwpharma]

Sanofi's Sarclisa gets FDA nod as first cancer drug delivered by on-body injector $SNY https://t.co/0mWRID5ds6

[FirstWord Pharma @fwpharma]

GSK calls time on Alector dementia pact $GSK $ALEC https://t.co/2aQ4iBVJnl

[FirstWord Pharma @fwpharma]

AstraZeneca, Ionis suffer setback with failure of key CV outcomes study for eplontersen $AZN $IONS https://t.co/PRocEV3loq

[FirstWord Pharma @fwpharma]

Sanofi promises to play nice as EU probe looks into flu vaccine campaign $SNY $CSL https://t.co/rgO83csUB7

[FirstWord Pharma @fwpharma]

Biopharma bites: Real-time CRL publishing on pause, plus Prime's gene-editing victory and more from Seres, Boehringer $PRME $BEAM $MCRB https://t.co/4PZ6QgWxyk

[FirstWord Pharma @fwpharma]

Scipher to merge with Chemomab after AI tool IDs opportunity in RA $CMMB https://t.co/q9xrxoLRGj

[FirstWord Pharma @fwpharma]

Satellos posts 'encouraging' six-month update for DMD candidate in adults $MSLE https://t.co/4p2GQHWOeg

[FirstWord Pharma @fwpharma]

MindRank banks $52M as AI-discovered GLP-1 pill advances in Phase III https://t.co/R6CIShdbcK

[FirstWord Pharma @fwpharma]

AstraZeneca turns to China again, this time for Sino Biopharm's experimental respiratory drug $AZN https://t.co/ddzHi1PYWY

[FirstWord Pharma @fwpharma]

AstraZeneca to leverage Helix's patient datasets to speed up drug R&D $AZN https://t.co/SBvaPpGBDt

[FirstWord Pharma @fwpharma]

Compass says psychedelic helps patients with resistant depression go into remission $CMPS https://t.co/vMKXjv2h6r

[FirstWord Pharma @fwpharma]

Following in Kailera's footsteps, obesity startup Kalohexis files to go public https://t.co/UDZqVN1eK2

[FirstWord Pharma @fwpharma]

Kailera posts positive top-line data for Hengrui-licensed oral GLP-1 $KLRA https://t.co/BLhhvGVN4f

[FirstWord Pharma @fwpharma]

FDA clears Vera's BAFF/APRIL blocker Trutakna for IgA nephropathy $VERA $OTSKF $VRTX https://t.co/lNXW44KoX7

[FirstWord Pharma @fwpharma]

With new name and €33M in hand, Cyllene targets pivotal study for lead DNA medicine https://t.co/o6ogc91XvE